Masafumi Iida

Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication

Lucas A. Horn, Paul L. Chariou, Sofia R. Gameiro et al. · Journal of Clinical Investigation · 2022 · 118 citations · Full text

Medicine, Immunology, Oncology +17

Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer

Masafumi Iida, Kouki Tsuboi, Takanori Ishida et al. · Breast Cancer · 2018 · 33 citations

Life Sciences, Endocrinology, Oncology +17

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer

Masafumi Iida, Misato Nakamura, Emi Tokuda et al. · Oncotarget · 2019 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC

Kristen Fousek, Lucas A. Horn, Haiyan Qin et al. · Journal of Thoracic Oncology · 2022 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Decreased ER dependency after acquired resistance to CDK4/6 inhibitors

Masafumi Iida, Daichi Toyosawa, Misato Nakamura et al. · Breast Cancer · 2020 · 21 citations

Medicine, Molecular Medicine, Chemotherapy +8